Home/ Stocks/ INM

InMed Pharmaceuticals Inc. Common Shares

INM XNAS

$0.65 -0.05 (-6.66%) ▼ 15-min delayed

Open

$0.72

High

$0.73

Low

$0.65

Volume

12.1K

Market Cap

$2.15M

About InMed Pharmaceuticals Inc. Common Shares

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 13 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2026	N/A	$-2,966,336	$-0.73
Q2 2026	$820.2K	$-2,028,223	$-0.51
Q1 2026	$1.12M	$-1,726,899	$-0.44
FY 2025	$4.94M	$-8,162,133	$-8.36

Related Market News

No specific coverage for INM yet. Check out our latest market news or earnings calendar.

Get INM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on InMed Pharmaceuticals Inc. Common Shares.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.